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Structure of an Enzyme Required
for Aminoglycoside Antibiotic Resistance
Reveals Homology to Eukaryotic Protein Kinases
Wai-Ching Hon,* Geoffrey A. McKay,* The mechanisms of antibiotic resistance developed
by bacteria are highly diverse (Davies, 1994). ResistancePaul R. Thompson,* Robert M. Sweet,²
Daniel S. C. Yang,* Gerard D. Wright,* to the class of clinically useful bactericidal antibiotics
known collectively as the aminoglycosides (compoundsand Albert M. Berghuis*
*Department of Biochemistry that include gentamicin, amikacin, and streptomycin) is
achieved through chemical modification of the antibi-McMaster University
1200 Main Street West otic. As a consequence of the modification, the amino-
glycoside loses its affinity for its target, the 16S ribo-Hamilton, Ontario, Canada L8N 3Z5
²Biology Department somal RNA of the 30S ribosomal particle (Fourmy et al.,
1996), and thus is unable to provide the interferenceBrookhaven National Laboratories
Upton, New York 11973 with translation that is required as a prelude to cell
death.
Three classes of aminoglycoside-modifying enzymes
have been identified in pathogenic bacteria: O-phos-Summary
photransferases (kinases), N-acetyltransferases, and
O-adenyltransferases (Shaw et al., 1993). Despite theBacterial resistance to aminoglycoside antibiotics is
importance of aminoglycoside therapy in the treatmentalmost exclusively accomplished through either phos-
of bacterial infections, there remains a paucity of struc-phorylation, adenylylation, or acetylation of the anti-
ture-function information for any drug-resistance en-bacterial agent. Theaminoglycosidekinase,APH(39)-IIIa,
zyme. The three-dimensional structure of an O-adenyl-catalyzes the phosphorylation of a broad spectrum of
transferase (kanamycin 4'-nucleotidyltransaferase) hasaminoglycoside antibiotics. The crystal structure of this
been elucidated (Sakon et al., 1993; Pedersen et al.,enzyme complexed with ADP was determined at 2.2 AÊ
1995). However, structural studies on either aminoglyco-resolution. The three-dimensional fold of APH(39)-IIIa re-
side phosphotransferases or acetyltransferases haveveals a striking similarity to eukaryotic protein kinases
been wanting. Over 20 distinct aminoglycoside kinasesdespite a virtually complete lack of sequence homol-
(APHs) have been identified in drug-resistant bacteriaogy. Nearly half of the APH(39)-IIIa sequence adopts a
(Shaw et al., 1993). These APH enzymes share extensiveconformation identical to that seen in these kinases.
primary sequence identity (20%±40%) and thus likelySubstantial differences are found in the location and
will have a comparable three-dimensional structure.conformation of residues presumably responsible for
One of the most studied APH enzymes is APH(39)-second-substrate specificity. These results indicate that
IIIa, carried by opportunistic pathogens of the generaAPH(39) enzymes and eukaryotic-type protein kinases
Enterococci and Staphylococci. This enzyme transfersshare a common ancestor.
the g-phosphate group from ATP to the 39 and/or 599
hydroxyl of a broad spectrum of aminoglycosides, in-Introduction
cluding the clinically important drug amikacin (McKay
et al., 1994b; Thompson et al., 1996b). APH(39)-IIIa is aOver the last few years, both the scientific and popular
264-residue enzyme that can either exist as a monomerpress have reported the dangers of the emerging bacte-
or as a covalent dimer linked through disulfide bridges.rial resistance to most, if not all, known antibiotics (Co-
The activity of the enzyme in the steady state is nothen et al., 1992; Lemonick, 1994; Travis et al., 1994). It
affected by dimer formation (McKay et al., 1994b). Weis clear fromthese reports that the evolution and dissem-
report herein the three-dimensional structure of thisination of antibiotic resistance genes has resulted in
aminoglycoside kinase and propose a catalytic mecha-serious difficulties in the treatment of bacterial infec-
nism for the detoxification of these important drugs. Thetions. There has not emerged a new class of antibacterial
structure of APH(39)-IIIa reveals a striking similarity toagents for many years, and while new targets are being
protein kinases and thus provides an unanticipated linkrecognized (e.g., Onishi et al., 1996), no antibiotics tar-
between antibiotic resistance and signal transductiongeting novel processes will likely appear in the clinics
in eukaryotes.in the near future. This observation has served to focus
attention onthe mechanisms of antibiotic resistance and
on the development of new compounds or treatment
Results and Discussionmethodologies that could circumvent resistance or de-
lay its emergence and spread (Travis, 1994). This strat-
Overall Architecture of APH(39)-IIIaegy requires a detailed understanding of the mechanism
and Similarity to Protein Kinasesof antibiotic resistance, preferably at the atomic level.
The structure of APH(39)-IIIa was determined by multi-Unfortunately, with the notable exception of the class
wavelength anomalous dispersion (MAD) techniques us-A and C b-lactamases (Herzberg et al., 1991; Chen et
ing protein containing selenomethionine residues. Crys-al., 1993; Imtiaz et al., 1994; Lobkovsky et al., 1994;
tals of native and selenomethionyl-modified proteinsBonomo et al., 1995), there are few examples of the
were grown in the presence of ATP, employing the hang-requisite molecular comprehension of antibiotic resis-
tance. ing-drop method and using PEG 8000 as a precipitant.
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Table 1. Structure Determination and Refinement
X-Ray Diffraction Data
Compl. (%) Rsyma ,I/s.
Data Set l (AÊ ) No. Refl. Unique [last shell] [last shell] [last shell] Resol. (AÊ )
Native 1.1050 242284 30934 96.4 [95.9] 0.055 [0.213] 11.8 [4.6] 2.2
Se-Met l1 0.9819 148910 33136 78.2 [36.4] 0.046 [0.179] 12.3 [2.4] 2.5
Se-Met l2 0.9815 130214 27756 82.2 [66.8] 0.045 [0.148] 13.2 [3.5] 2.7
Se-Met l3 0.9110 124782 26734 78.9 [62.5] 0.045 [0.142] 13.4 [3.1] 2.7
Phasing Statistics (25-2.8 AÊ )b
Isomorphous Anomalous
Derivative No. Refl. Phasing Power Figure of Merit No. Refl. Phasing Power Figure of Merit
Se-Met l1 ± ± ± 8205 2.11 0.41
Se-Met l2 9001 2.88 0.38 8009 2.49 0.43
Se-Met l3 8725 2.32 0.33 8705 1.43 0.32
Refinement Statistics (40±2.2 AÊ )c
rms Deviations
R-factor (%)
Protein Atoms Mg21 Ions Solvent Molecules [Free R-factor] Mean B Factor (AÊ 2) Bonds (AÊ ) Angles (8)
Native 4536 4 138 22.2 [29.0] 21.3 0.008 1.3
a Rsym 5 S | I 2 ,I. |/S ,I., where I 5 observed intensity, ,I. 5 average intensity from multiple observations of symmetry related reflections.
b For phase determination, the Se-Met l1 data set was treated as the native data set, explaining the absence of values under the isomorphous
column. Tabulated are the number of phased reflections, the phasing power of these reflections, and the figure of merit resulting from that
single contribution. The overall figure of merit was 0.71. All values were calculated with the PHASES package.
c A bulk solvent model, as implemented in XPLOR, was used in the refinement.
These crystals belonged to the spacegroup P212121 (a 5 identification of 10 of the possible 12 selenium sites (6
methionine residues permonomer). The electron density49.7 AÊ ; b 5 91.2 AÊ ; c 5 131.3 AÊ ) and contained the
map generated using this information combined withdimeric species in the asymmetric unit. A 2.2 AÊ data set
solvent flattening restraints was of such quality that 80%for the native enzyme and a 2.7 AÊ MAD data set (3
of the protein structure could be readily identified. Thewavelengths) for the selenomethionyl derivative were
remainder of the structure was built during the coursecollected on the NSLS beamline X12-C at Brookhaven
of refinement. In the early stages of model building, itNational Laboratories (see Experimental Procedures;
was realized that the crystal structure did not containTable 1). Analysis of the MAD data set allowed for the
an ATP molecule in the active site as expected, but
rather an ADP was found. ATP in solution is prone to
hydrolysis over time (stability is approximately 1 week),
and clearly ithad hydrolyzedduring the 4 weeksrequired
to grow crystals (Figure 1). The structure currently has
been refined to a crystallographic R-factor of 22.2% and
an R-free of 29.0% using native data with Fobs . 1s Fobs
in the resolution shell 40±2.2 AÊ . The model contains the
complete 263-residue protein chain for both monomers
(the N-terminal methionine is cleaved during expression
in E. coli), 2 ADP molecules, 4 magnesium ions, and 138
ordered solvent molecules. Over 96% of the nonglycine
residues are placed within the most favorable region of
the Ramachandran plot, and none are located in disal-
lowed areas, as defined within the program PROCHECK
(Laskowski et al., 1993).
The two APH(39)-IIIa molecules found in the asymmet-
ric unit are covalently attached through two cysteine
bridges in a head-to-tail±tail-to-head fashion (Figure 2).
Cys-19, which is located in a b sheet (b1), is linked to
Cys-156 of the partner molecule, and vice versa. Cys-
156 is part of a loop region between two helices (aA
Figure 1. Electron Density Map of APH(39)-IIIa about the Nucleotide
and aB). This loop region is likely to possess extensive
The 2Fo±Fc map was calculated using the final model phases to 2.2 conformational flexibility in solution, as can be inferred
AÊ resolution and contoured at 1s. Shown are the ADP molecule,
from the above-average thermal factors for this seg-the conserved residues Asn-195 and Asp-208, the two associated
ment. One can assume, therefore, that the linkage be-magnesium ions, and several ordered water molecules that coordi-
tween the two monomers will allow for a pliable hingenate to the nucleotide and/or form part of the octahedral coordina-
tion shells around the magnesium ions. motion under physiological conditions. This assumption
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Figure 2. Three-Dimensional Structure of the
APH(39)-IIIa Dimer
(A) View of the dimer parallel to the 2-fold axis.
The two APH(39)-IIIa monomers are covalently
linked through two cysteine bridges between
Cys-19 and Cys-156 of the partner molecule in
a head-to-tail±tail-to-head fashion.
(B) View ofthe dimer perpendicular to the 2-fold
axis, rotated 908 about the horizontal axis.
There are no extensive interactions observed
between the two monomers beyond what is
expected for regular crystal packing contacts.
This image and following ones were gener-
ated using MOLSCRIPT (Kraulis, 1991) and
RASTER3D (Merritt and Murphy, 1994) soft-
ware. Secondary-structure elements were as-
signed using the program DSSP (Kabsh and
Sander, 1983).
is strengthened by the observation that besides the two significant deviation from the classical ePK fold observed
in the N-terminal lobe of APH(39)-IIIa is in the loop betweencysteine bridges, there are few interactions between the
two monomers present in the crystal. The only signifi- b strands 1 and 2. In protein kinases, this is the location
of the highly conserved G-X-G-X-X-G motif (Hanks et al.,cant interactions observed are a hydrogen-bond net-
work between Asp-150 and the side-chains of Arg-5 and 1988; Hanks and Hunter, 1995); however, in APH(39)-IIIa
this motif is not observed, and a 1-residue insertion isTrp-85 of the partner molecule.
In the dimer, the active sites of the two monomers present that results in a different conformation from that
found in ePKs.face each other (Figure 2A). However, these sites are
separated by about 20 AÊ , and it is probable that they The 12 residues that connect the N- and C-terminal
lobes also display structural similarity to the homolo-are independent. This observation, combined with the
likely flexible linkage between the two monomers, leads gous residues of ePKs. The APH(39)-IIIa tethering seg-
ment consists of a short 5-residue helix flanked on bothto the prediction that there is no cooperative or antago-
nistic effect between the APH(39)-IIIa monomers in the sides by regions of random coil. However, the location
of the helix is shifted approximately 7 AÊ with respect todimer form. This assessment agrees with steady-state
kinetic measurements (McKay et al., 1994b). where it is commonly found in protein kinase structures
such as MAPK and cAPK. This is a result of structuralThe APH(39)-IIIa monomer is composed of two lobes,
a smaller 94-residue N-terminal lobe and a large 157- differences in the C-terminal lobe between APH(39)-IIIa
and ePKs that prevent identical positioning of this seg-residue C-terminal lobe, tethered by a 12-residue stretch
containing a short b strand and a helix. The deep cleft ment (see below). One of these differences results in
the first two residues of the tethering segment (residuesbetween the two lobes is the location of the ATP-binding
site (Figure 3A). The architecture of the N-terminal lobe 96 and 97) becoming part of a short three-stranded
antiparallel b sheet (bA, b6, and b7; Figure 3A).is similar to that seen for the N-terminal lobes of Ser/
Thr and Tyr protein kinases, such as the catalytic subunit The C-terminal lobe can be subdivided into three re-
gions: (i) a central core region consisting of two helicesof cAMP-dependent protein kinase (cAPK), the catalytic
domain of casein kinase-1 (CsK), MAP kinase ERK2 (a4 and a5) and a long hairpin-shaped loop that incorpo-
rates two short stretches of antiparallel b sheet (b6±b9);(MAPK), the catalytic domain of phosphorylase kinase
(PhK), and the insulin receptor kinase (IRK) (Knighton et (ii) an insert region located between a4 and b6, com-
posed of two helices (aA and bB) connected by a longal., 1991; Taylor et al., 1992; Hubbard et al., 1994; Zhang
et al., 1994; Owen et al., 1995; Xu et al., 1996). We will 19-residue loop structure; and (iii) the C-terminal region
comprised of helices aC and aD (Figure 3). The centralrefer to thesekinases as eukaryotic-type protein kinases
(ePKs) to distinguish them from bacterial protein kinases core region displays a surprisingly high degree of con-
formational similarity to several segments invariantlyhereafter. The N-terminal lobe of APH(39)-IIIa consists
of a five-stranded antiparallel b sheet (b1±b5), with a helix present in ePKs. For example, superposition of these
segments between APH(39)-IIIa and cAPK gives an rmslocated between strand 3 and 4 (a2; Figure 3B). Further-
more,as is seen in MAPK and IRK, the b sheet is preceded deviation for main-chain atoms of 1.88 AÊ , although there
is less than 10% identity at the sequence level betweenby a short 310 helix (a1) (Hubbard et al., 1994; Zhang et
al., 1994). The architectural similarity between APH(39)-IIIa the aminoglycoside kinase and ePKs (Figure 4). There
are four main structural differences between APH(39)-and these protein kinases is also conserved in the three-
dimensional organization. For example, the rms deviation IIIa and ePKs in this core region. First, the a4 helix is
four residues shorter at the N-terminal end than thefor structurally conserved main-chain atoms in the N-ter-
minal lobe between APH(39)-IIIa and cAPK, a prototypical homologous helix in ePKs, partly explaining the shifted
position in the tethering segment. Second, an insert isePK, is only 1.83 AÊ . This is surprising, since the sequence
identity between APH(39)-IIIa and ePKs for these residues located between a4 and b6 in APH(39)-IIIa, as discussed
below. Furthermore, a highly conserved polypeptide-is less than 6% (between ePKs the identity is greater
than twice that at approximately 14%) (Figure 4). The only chain segment located between b9 and a4 in ePKs,
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a4 and b strand b6. The insert consists of two antiparal-
lel-oriented helices (aA and aB) connected by a 19-
residue-long stretch containing Cys-156, which is in-
volved in dimer formation (see above). In ePKs, the
space occupied by the aA±aB insert is occupied by a
different sequence that is foreign to APH(39)-IIIa. This
insert is placed between b9 and a5 and is generally
much smaller (26±36 residues). Furthermore, the eukary-
otic insert has a distinctly different conformation. It is
well established that the insert present in eukaryotic
protein kinases is responsible primarily for the specific-
ity and selectivity of substrates (Taylor et al., 1992; Mad-
husudan et al., 1994). In many ePKs, this insert also
corresponds to the activation segment, i.e., it contains
the sites of phosphorylation that transform the protein
kinase from an inactive into an active conformation
(Johnson et al., 1996; Yamaguchi and Hendrickson,
1996). The 60-residue insert in APH(39)-IIIa could per-
form the analogous function of substrate selection for
aminoglycoside-phosphorylating enzymes. Its location,
directly in front of the active site, leaves it perfectly
poised to interact with a substantial part of theaminogly-
coside antibiotic. Consistent with the absence of the
ePK activation loop in APH(39)-IIIa, regulation by phos-
phorylation has not been observed.
The C-terminal region of the C-terminal lobe consists
of two helices, helix aC, which is placed across the
bottom of the molecule, and helix aD, which points back
upward with its end in close proximity to the ATP-bind-
ing pocket. In ePKs, the remainder of the conserved
structure after helix a5 also consists of two helices, but
their positions differ and bear no resemblance to that
seen in APH(39)-IIIa. The only weak similarity present is
that the aD helix occupies the same place in space
as the first helix following a5 in ePKs. However, theFigure 3. Structure of APH(39)-IIIa and Comparison with Eukaroytic-
orientation of the ePKs helix is opposite to that seen inType Protein Kinases
APH(39)-IIIa.(A) Shown are the structures of APH(39)-IIIa and residues 35±280 of
the catalytic subunit of cAMP-dependent protein kinase (cAPK, PDB
code 1ATP [Bernstein et al., 1977]) in identical orientations (Knighton
et al., 1991). The segments that differ between APH(39)-IIIa and ePKs Active Site of APH(39)-IIIa
have been color coded as follows: G-X-G-X-X-G loop, red (area I); Our previous work demonstrated that APH(39)-IIIa
tethering segment, yellow (area II); APH insert, orange (area III); ePK
operates by a Theorell-Chance kinetic mechanism. Thisinsert, purple (area IV); C-terminal region, blue (area V).
sequential mechanism consists first of ATP binding fol-(B) Topological diagram of secondary-structure elements in APH(39)-
lowed by binding and phosphorylation of the aminogly-IIIa. Areas that have a background panel indicate differences in
folding between APH(39)-IIIa and ePKs, with the ePK fold repre- coside, release of the modified drug, and rate-limiting
sented in gray. Color coding for the background panels follows that dissociation of ADP (McKay and Wright, 1995, 1996).
described above. Positional isotope-exchange experiments were consis-
tent with direct phosophoryl transfer to the aminoglyco-
side and not with a phosphoenzyme intermediate
which is responsible for substrate specificity (Taylor et (Thompson et al., 1996a). The latter mechanism had
al., 1992; Madhusudan et al., 1994), is conspicuously been proposed based on the presence of an invariant
absent. And finally, the tip of the hairpin loop, containing histidine in APH(39) enzymes (His-188) (Martin et al.,
the mini-b sheet b7±b8 is rotated to place it partly in 1988). His-188 is part of a conserved sequence H-G-D-
the space that, in ePK structures, is occupied by the a3 X-X-X-X-N that has a counterpart in subdomain VIB of
helix homolog. As a result of this alternative position of ePKs, H-R-D-L-K-X-X-N, a similarity that has beennoted
the hairpin tip and the consequential difference in the previously (Heinzel et al., 1988; Martin et al., 1988). Crys-
conformation of the tethering segment, the mini-b sheet tal structures of several protein kinases, along with mu-
b7±b8 is extended by one extra strand coming from the tagenic and mechanistic studies, have implicated the
tethering segment (bA). faithfully conserved Asp residue of this motif (Asp-166
The remaining two regions of the C-terminal lobe devi- in cAPK) with the role of catalytic base required for
ate from the classical ePK fold. As mentioned above, in deprotonation of the substrate hydroxyl group for effi-
cient attack at the g-phosphate of ATP. The structureAPH(39)-IIIa a 60-residue insert is present between helix
Structure of an Aminoglycoside Kinase
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Figure 4. Sequence Alignment between APH(39)-IIIa and Eukaroytic-Type Protein Kinases
Structure-based sequence alignment between APH(39)-IIIa, cAPK, the catalytic domain of casein kinase-1 (CsK, PDB code 2CSN), MAP kinase
ERK2 (MAPK), and the catalytic domain of phosphorylase kinase (PhK, PDB code 1PHK) (Knighton et al., 1991; Taylor et al., 1992; Hubbard
et al., 1994; Zhang et al., 1994; Owen et al., 1995; Xu et al., 1996). Residues with a lightly shaded background were found in structurally
identical locations. Based on the comparison of numerous ePK sequences (Hanks et al., 1988; Hanks and Hunter, 1995), residues that are
shown boxed are either functionally conserved (darkly shaded background) or absolutely conserved (closed background). Inserts are shown
as open boxes, and the number displayed indicates the number of residues that are inserted at that location. Color coding and numbering
of segments that differ between APH(39)-IIIa and ePKs follows that of Figure 3.
of APH(39)-IIIa predicts a similar role for Asp-190, as this role in catalysis in both ePKs and APH(39)-IIIa, perhaps
in proper orientation of the nucleophilic hydroxyl orresidue is positioned appropriately for interaction with
by enhancing the electrophilicity of the g-phosphatethe incoming substrate hydroxyl (Figure 5). Site-directed
through direct or indirect hydrogen bonding (Madhusu-mutagenesis of Asp-190 to alanine results in an enzyme
dan et al., 1994; Cole et al., 1995).with only residual activity (at least 650-fold decrease in
We had predicted previously that Lys-44 and Lys-33kcat) and supports the predicted role of this residue in
would line the ATP-binding pocket, based on APH(39)-catalysis (Table 2). More recent analyses of the role of
IIIa inactivation by the ATP analog fluorosulfonylbenzoylthe conserved Asp in cAPK (Madhusudan et al., 1994)
adenosine followed by peptide mapping (McKay et al.,and CsK (Cole et al., 1995) have questioned the pro-
1994a). Lys-44 is conserved in all APH(39) enzymes,posed general-base role for the conserved Asp. None-
while Lys-33 is unique to APH(39)-IIIa and -VIIa. Thetheless, the active-site Asp no doubt plays a critical
current structure validates these predictions. Lys-44 is
located on b strand 3 and positioned directly over the
ATP triphosphate±binding site, where it interacts with
the a- and b-phosphates (Figure 5). Lys-33 is in b strand
2, also in the ATP-binding region, but positioned above
the adenosine ring and does not appear to be forming
interactions with the nucleotide. Site-directed mutagen-
esis of these lysine residues supports the importance
of Lys-44 and not Lys-33 in ATP binding (Table 2). Only
Lys-44 to Ala mutants had any effect on the steady-
state kinetics of APH(39)-IIIa, and only on the Km for
ATP. As ATP is the first substrate entering in a Theorell-
Chance kinetic mechanism, KmATP is a direct measure-
ment of the binding affinity of nucleotide to the enzyme.
The difference in binding energy is 2.1 kcal/mol, consis-
tent with an ion-pair interaction (Wells et al., 1987).
Therefore, both structural and mutagenic evidence sup-
Figure 5. The Nucleotide Binding Site port an important contribution of Lys-44 in substrate
The nucleotide-binding pocket is located in the cleft between the binding.
N- and C-terminal lobes. The uniformly conserved residues Lys-44,
Lys-44 is homologous to the conserved lysine foundGlu-60, Asp-190, Asn-195, and Asp-208 form interactions with ADP
in subdomain II of the protein kinase superfamily (e.g.,and the two magnesium ions. Also shown is the location of Lys-33,
Lys-72 in cAPK) where, based on all ePK structureswhich is in the binding pocket but does not form interactions with
the nucleotide. determined to date, this residue is also positioned for
Cell
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Table 2. Steady-State Kinetic Parameters of APH(39)-IIIa Mutants
ATP Kanamycin A
Mutant Km (mM) kcat (s21) Km (mM) kcat (s21)
Wild type 21.4 6 1.2 1.83 6 0.11 15.9 6 1.7 2.04 6 0.15
K33A 14.0 6 1.5 0.62 6 0.03 17.4 6 3.4 0.68 6 0.04
K44A 566 6 49 1.58 6 0.07 24.8 6 3.2 1.28 6 0.12
K33A, K44A 640 6 89 0.62 6 0.08 23.3 6 7.5 0.56 6 0.012
D190Aa ± #0.0033 6 0.0003 ± #0.0033 6 0.0003
a Owing to the extremely low values of kcat for the D190A mutant, an estimate of the Km for either ATP or Kanamycin A could not be made.
direct interaction with the a- and b-phosphates of ATP. that are dispersed over the sequence, there is a complete
lack of sequence homology (Figure 4). Specifically, theSite-directed mutagenesis of the conserved lysine in
several ePKs reveals a surprising difference in the role signature sequence H/Y-R-D-L/I-K-P-X-N for Ser/Thr ki-
nasesorH-R-D-L-R/A-A-A/R-N for tyrosine kinases,whichthis residue plays in these enzymes when compared to
APH(39)-IIIa. Here, the primary effect of the loss of the is located between b6 and b7, is only loosely conserved
(H-G-D-L-G-D-S-N) and does not conform to either motif.lysine residue is felt by changes in kcat and not in Km
(Gibbs and Zoller, 1991; Robinson et al., 1996). Since, Moreover, the G-X-G-X-X-G sequence between b1 and
b2 is completely absent, further obscuring the homologyin a Theorell-Chance kinetic mechanism, kcat reflects
only the first-order rate of dissociation of ADP from the between APH(39) enzymes and protein kinases. Piepers-
berg and coworkers did predict the relationship betweenE±ADP complex, an effect on the phosphorylation event
per se would not bereadily detected. Nonetheless, there aminoglycoside phosphotransferases and ePKs based on
sequence comparison (Heinzel et al., 1988; Piepersbergis a clear difference in the primary impact of the muta-
genesis of this residue in APH(39)-IIIa versus ePKs. et al., 1988). In fact, in their analyses they correctly identi-
fied the conserved lysine in strand b3, as well as theMutagenesis of APH(39)-IIIa thus has served to vali-
date the proposed location of the active site predicted residues located between strands b6 and b9, although
their sequence alignment deviates substantially from theby this structure. Furthermore, it has suggested a mech-
anism for phosphoryl transfer, i.e., direct attack of the one presented here (Figure 4). Also, immediately prior to
determining the structure of APH(39)-IIIa, we proposednucleophilic hydroxyl assisted by Asp-190, that is highly
similar to ePKs. this relationship based on mutagenesis studies of histi-
dine residues and isotope-effect experiments (Thomp-
son et al., 1996a).Relationship between APH(39) Enzymes
and Protein Kinases Given a relationship between APH(39) enzymes and
the protein kinase superfamily, the obvious questionThe surprising similarity between APH(39)-IIIa and the
ePKs, both in three-dimensional fold as revealed by X-ray that arises is, what is the origin of the similarity? The
notion that convergent evolution is responsible for thecrystallography and in functional conservation of several
active-site residues as shown by mutagenesis studies, similarity between the two classes of enzymes is highly
improbable (Doolittle, 1994), and we are left with theprovides overwhelming evidence that the bacterial 39-
aminoglycoside-phosphorylating enzymes and the en- conclusion that APH(39) enzymes and ePKs must have
evolvedfrom a common ancestor. It has been suggestedzymes from the protein kinase superfamily are related.
To recapitulate, over 40% of the APH(39)-IIIa enzyme is that aminoglycoside-modifying enzymes found in path-
ogenic organisms originated from bacteria that producestructurally identical to that of ePKs like cAPK (Figures
3 and 4). Specifically, the N-terminal lobe and the central these antibacterial drugs, primarily Streptomycetes,
where these enzymes function as a protection mecha-core of the C-terminal lobe are conserved between the
two classes of enzymes. The rms deviation between nism against indigenously produced compounds (Ben-
veniste and Davies, 1973). Indeed, the APH(39) types IVAPH(39)-IIIa and cAPK for these residues is z1.8 AÊ ,
which is higher than, but comparable to, what is seen and V, which are found in aminoglycoside producers,
show 20%±30% amino acid similarity to APH(39)-IIIabetween different ePKs (Yamaguchi and Hendrickson,
1996). Of the 12 absolutely conserved residues found (Shaw et al., 1993).
While aminoglycoside kinases appear tohave originatedin eukaryotic protein kinases (Hanks et al., 1988; Hanks
and Hunter, 1995), 10 are located in areas also present from antibiotic-producing organisms, this does not readily
explain the similarity to ePKs. Recently, however, severalin APH(39)-IIIa, and of those, 7 are conserved in the
aminoglycoside phosphotransferase family. Furthermore, ePKs have been foundin bacteria, especially Streptomy-
cetes, and it is now realized that signal-transductionthe residues conserved between APH(39) enzymes and
protein kinases appear to have similar functions in antibi- pathways involving Ser/Thr and Tyr kinases are not re-
stricted to eukaryotes (for review, see Kennelly andotic resistance and protein phosphorylation.
In hindsight, it is almost surprising that, except for a Potts, 1996; Zhang, 1996). Furthermore, many of the
steps involved in aminoglycoside biosynthesis havefew publications (Brenner, 1987;Heinzel et al., 1988;Martin
et al., 1988; Thompson et al., 1996a), the relationship be- been shown to require specific hydroxyl-group phos-
phorylation, perhaps by enzymes with similar structurestween APH(39) enzymes and ePKs was not generally real-
ized before. This can be attributed to the fact that, except to APHs and ePKs. Thus, an attractive possible origin
for aminoglycoside kinases is that ancestral bacterialfor the seven conserved and three homologous residues
Structure of an Aminoglycoside Kinase
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X-Ray Data Collection, Structure Determination,protein kinases were recruited for the biosynthesis of
and Refinementsecondary metabolites (Piepersberg et al., 1988). These
Data sets for both the native and Se-Met derivative were collectedkinases also provided a means of protection against the
on the beamline X12-C of the National Synchrotron Light Source,
toxic side effects of these compounds, or perhaps it is which was equipped with a hybrid diffractometer on which a MAR
the phosphorylated metabolite that is needed by the Research Co. imaging-plate system was mounted on an Enraf Non-
ius CAD-4-style goniometer. The data collection was performedorganism, and the toxic effects of the unmodified com-
under cryo-conditions (110 K), which allowed for the use of onlypound are fortuitous but useful to the producing organ-
one crystal for the native data set and one crystal for the completeism in the soil. An alternative hypothesis is that the
three-wavelength MAD data set. The wavelengths collected for theancestral kinase was required for metabolite biosynthe-
MAD data sets corresponded to the energy maxima for the real and
sis and then diverged toacquire exclusive protein kinase imaginary components of the anomalous scattering, plus one at
activity. higher energy than the selenium-absorption edge. Data reduction
of the raw images was carried out with the DENZO/SCALEPACKRegardless of the precise origins of the divergence
programs (Otwinowski and Minor, 1997). Calculations for phase de-of these kinases, comparison of the three-dimensional
termination and refinement were performed using programs of thestructures of APH(39)-IIIa and ePKs may allow us to
PHASES package (Furey and Swaminathan, 1990, Amer. Cryst.speculate on the characteristics of the common ances-
Assoc. Mtg. Summ. [Series 2], abstract). The location of 10 of the
tor. It is probable that common features present in both possible 12 (2 3 6) Se sites was determined by inspection of differ-
classes of enzymes must also be present in the ances- ence and anomalous Patterson maps. The remaining selenium
atoms belonged to the two Met-26 residues. The final structuretor. Regarding the inserts present in the C-terminal core
shows that Met-26 displays multiple side-chain conformations inregion (Figure 3, areas III and IV), one can speculate that
both monomers. Refinement of the selenium positions resulted inthey were perhaps absent in the common ancestor and
an overall figure of merit of 0.71 for 9616 reflections to 2.8 AÊ . Afterthat different inserts evolved placed either between a4
solvent flattening (Wang, 1985), the electron density map was of
and b6 or b9 and a5, depending on the type of sub- excellent quality, and most of the structure could be traced readily
strates. The observed differences in the two C-terminal using the program O (Jones et al., 1990). The remaining parts of the
structure were built in the course of refinement by examinationhelices between APH(39)-IIIa and ePKs (Figure 3, area
of sa-weighted difference maps (Read, 1986). Reciprocal space-V) does not give us any obvious clue regarding the com-
restrained refinement was carried out in XPLOR (BruÈnger, 1992b),mon ancestor.
with 10% of the data excluded for calculation of free R-factorsIn conclusion, the structure of APH(39)-IIIa gives us
(BruÈ nger, 1992a, 1993). In the early stages of refinement, data from
not only a view of an enzyme class that is capable of the selenomethionine derivative was used for refinement, but when
detoxifying antibiotics and is responsible for a clinically the model reached a sufficient quality, refinement was carried out
against the 2.2 AÊ native data set. The current model has been refinedrelevant form of antibiotic resistance, but it also presents
against data between 40±2.2 AÊ resolution, with Fobs . 1s Fobs, andus with a satellite member of the protein kinase super-
has a crystallographic R-factor of 22.2% and an R-free of 29.0%.family. In addition, given the high degree of amino acid
sequence similarity between APH enzymes, the struc-
Generation of APH(39)-IIIa Site Mutants
ture provides valuable insight into the architecture and and Steady-State Kinetic Analyses
mechanism of these enzymes. This information now can Site mutants were prepared by PCR using the megaprimer method
be exploited for the rational design of inhibitors of (Sarkar and Sommer, 1990), with plasmid pETSACG1 (Thompson et
al., 1996a) as template. Mutant genes were sequenced in their en-aminoglycoside kinases, which could find use in re-
tirety to ensure that no secondary mutations occurred during ampli-versing antibiotic resistance.
fication. Mutant enzymes were purified to homogeneity and assayed
by coupling ADP release to NADH oxidation as previously describedExperimental Procedures
(McKay et al., 1994b). Steady-state kinetic parameters were evalu-
ated from initial velocities by direct fitting to the standard Michaelis-Protein Expression, Purification, and Crystallization
Menten equation or to an equation describing substrate inhibition,Native APH(39)-IIIa protein was purified using methods previously
if appropriate (McKay et al., 1994b), using the Grafit, 3.0 softwaredescribed (McKay et al., 1994b). To obtain the selenomethionine-
package (Leatherbarrow, 1992). Errors are the standard errors de-enriched APH(39)-IIIa derivative used in the MAD experiment, the
rived from direct fitting to the equations.following procedures were used. The Met auxotroph E. coli
B834(DE3)/pLys S (gift from Dr. A. Edwards, McMaster University)
Acknowledgmentswas transformed with plasmid pETSACG1 containing the APH(39)-
IIIa gene (Thompson et al., 1996a). Cells were grown at 378C in
We thank Byron DeLaBarre, Adelaine Leung, Laura Rossi, AdrianLeMaster's medium supplemented with Se-Met (50 mg/L) (LeMaster
Christilaw, and Susan Xue for their help during crystallization andand Richards, 1985). APH(39)-IIIa production was induced by the
data collection. Furthermore, we thank Dr. E. J. Goldsmith for provid-addition of IPTG to 1 mM final concentration when the cell density
ing us with the coordinates of MAPK. We acknowledge the Nationalgave an absorbance reading at 600 nm of 0.9. Cells were grown for
Cancer Institute for allocation of computing time and staff supportan additional 4 hr and harvested by centrifugation. Enzyme was
at the Biomedical Supercomputing Center of the Frederick Cancerpurified and assayed as previously described (McKay et al., 1994b).
Research and Development Center. Beamline X12-C in the NationalSe-Met enrichment had no effect on steady-state kinetic parame-
Synchrotron Light Source at Brookhaven National Laboratory is sup-ters, and electrospray mass spectrometry confirmed the expected
ported by the United States Department of Energy Offices of Healthmolecular mass.
and Environmental Research and of Basic Energy Sciences, and byCrystals of native and selenomethionyl-modified proteins were
the National Science Foundation. This work was supported by agrown in the presence of ATP by hanging-drop vapor diffusion (Mc-
contract from the Canadian Space Agency to D. S. C. Y. and grantsPherson, 1982). Crystallization was observed when 5±10 ml of protein
from the Medical Research Council of Canada to A. M. B. (MT-solution (with 5-fold molar excess of ATP) at a concentration of 14
13107) and G. D. W. (MT-13536). G. A. M. and P. R. T. are recipientsmg/ml was mixed with an equal volume of reservoir solution, with the
of Natural Sciences and Engineering Research Council of Canadareservoir solution containing 0.1 M sodium cacodylate (pH 6.5), 0.2 M
graduate scholarships.magnesium acetate, and 20%±30% PEG 8000. Crystals thus obtained
belonged to the space group P212121 (a 5 49.7 AÊ ; b 5 91.2 AÊ ; c 5
131.3 AÊ ) and contained the dimeric species in the asymmetric unit. Received March 26, 1997; revised May 12, 1997.
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